PHARMACOSMOS
At Pharmacosmos, we are specialists in iron therapy. they develop, manufacture and market medicines for the treatment of iron deficiency anaemia in humans and animals. they are furthermore specialists in developing and producing advanced carbohydrates for pharmaceutical and technical uses.
PHARMACOSMOS
Industry:
Biotechnology Manufacturing
Address:
Denmark, South Carolina, United States
Country:
United States
Website Url:
http://www.pharmacosmos.com
Status:
Active
Contact:
+45 5948 5959
Email Addresses:
[email protected]
Technology used in webpage:
IPv6 3 To 9 CcTLD Redirects ASP.NET Core Kestrel About Cookies
Similar Organizations
National Science Foundation
Americaโs Seed Fund at the National Science Foundation awards nearly $200 million annually to startups and small businesses.
Vanrx Pharmasystems
Vanrx Pharmasystems manufactures aseptic filling machines that improve the production of sterile injectables.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-11 | Abfero Pharmaceuticals | Abfero Pharmaceuticals acquired by Pharmacosmos | N/A |
Official Site Inspections
http://www.pharmacosmos.com Semrush global rank: 4.81 M Semrush visits lastest month: 1.89 K
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Pharmacosmos"
Who we are - Pharmacosmos
We want to change the way iron deficiency is prevented and treated.See details»
Challenge Iron Deficiency & Anaemia - Pharmacosmos
We are Pharmacosmos. We want to change the way iron deficiency is prevented and treated. Explore Pharmacosmos. Pharmacosmos is... A global pioneer in carbohydrate chemistry and a leader in the development of innovative โฆSee details»
WHO WE ARE - pharmacosmos.com
Pharmacosmos was established in 1965 by Henry Christensen MD, PhD, who was succeeded by his youngest son Lars Christensen, MD, as CEO in 1993. The company has since its โฆSee details»
Pharmacosmos - Leadership Team - The Org
The Leadership Team at Pharmacosmos oversees the strategic direction and overall operations of the company. Comprising senior executives from various departments, including finance, โฆSee details»
Pharmacosmos - Wikipedia
Pharmacosmos was founded in Denmark in 1965 by Henry Marinus Christensen, M.D., Ph.D. Pharmacosmos' corporate headquarters, manufacturing facilities and research laboratories are located in Holbaek, Denmark (Scandinavia). The company has its own marketing, sales and services operations in Denmark and US, UK, Ireland, Germany, Sweden, Norway and China. In other geographies, the company partners with other pharmaceutical companies responsible for local โฆSee details»
Pharmacosmos - Management Team - The Org
The Management Team at Pharmacosmos is responsible for overseeing the strategic direction, financial health, and commercial success of the company. They ensure effective governance, โฆSee details»
Org Chart Pharmacosmos Group - The Official Board
The organizational chart of Pharmacosmos Group displays its 16 main executives including Tobias Christensen, Henrik Parker and Lars Thomsen. Toggle navigation The Official Board. โฆSee details»
About Pharmacosmos | PHARMACOSMOS
Pharmacosmo s Therapeutics is a U.S. specialty pharmaceutical company focused on IV iron treatment of Iron Deficiency Anemia. Our goal is to support patients and healthcare professionals with a range of iron therapies, tools and โฆSee details»
Global presence - Pharmacosmos
P โฌܯùyÏåDLi3¿โขaýéõÖQÉล ú ลพÀ6โÿ K NลธSsòC~)íโฌIqลกà +@W¹7É )?;9 &¦ý¦M{]โÒÆ โÒ´Ù ÁÁhr÷ª]e¡¹æÔÊqY โก-âüโõ Z°ü Ê"โ ÿSee details»
Pharmacosmos - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +45 5948 5959 At Pharmacosmos, we are specialists in iron therapy. they develop, manufacture and market medicines for the treatment of iron deficiency anaemia in humans โฆSee details»
Pharmacosmos - sabm.org
Pharmacosmos Therapeutics Inc. 120 Headquarters Plaza East Tower, 6th Floor. Morristown, NJ 07960 . Quick Links. Renew Now; Donate Today; A&A - SABM's Official Journal; SABM PBM โฆSee details»
Sustainabillity | PHARMACOSMOS
Pharmacosmos is a family held and family led company. We favor long-lasting solutions over short-term gains, and we are focused on maintaining a flat organization to empower โฆSee details»
Pharmacosmos - Marketing and Sales - The Org
The Marketing and Sales team at Pharmacosmos is responsible for strategizing and implementing plans to promote and sell their iron therapy products. This involves market analysis, managing โฆSee details»
Pharmacosmos A/S - Drug pipelines, Patents, Clinical trials - Synapse
Jan 23, 2025 Explore Pharmacosmos A/S with its drug pipeline, therapeutic area, technology platform, 97 clinical trials, 179 news, and 60 literature, Disease Domain:Hemic and Lymphatic โฆSee details»
Pharmacosmos - Overview, News & Similar companies - ZoomInfo
View Pharmacosmos (www.pharmacosmos.com) location in Zealand, Denmark , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Pharmacosmos - Medical and Clinical Management | The Org
The Medical and Clinical Management team at Pharmacosmos is responsible for overseeing clinical trials, ensuring regulatory compliance, managing clinical data, and providing strategic โฆSee details»
Pharmacosmos Company Overview, Contact Details
Pharmacosmos. Pharmaceutical Manufacturing Holbaek, Denmark 501-1000 Employees. Pharmacosmos is considered a world leading authority in treatment of iron deficiency โฆSee details»
Pharmaceuticals - Pharmacosmos
We want to change the way iron deficiency is prevented and treated.See details»
Presence in 40 countries - Pharmacosmos
We are Pharmacosmos. We want to change the way iron deficiency is prevented and treated.See details»
Pharmacosmos Group to Acquire G1 Therapeutics
Aug 7, 2024 โG1 and Pharmacosmos have a shared commitment to people living with cancer; the transaction announced today will enable a more rapid uptake of COSELA into the ES โฆSee details»